Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇿🇦ZA · Medicine#191500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
250 to 1.5K🎙 Weekly cadence·25 episodes·Last published 6d ago - Monthly Reach
Unique listeners across all episodes (30 days)
500 to 3K🇿🇦100% - Active Followers
Loyal subscribers who consistently listen
200 to 1.2K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
Antimicrobial resistance National Action Plans and the role of microbial genomics with with Kate Baker and Tess Johnson
Jun 24, 2026
33m 53s
Henriette Nielsen on vaginal microbiota transplantation
May 25, 2026
16m 53s
Zakiul Hassan and Tahmina Shirin on Nipah virus disease
Apr 13, 2026
37m 01s
Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing
Mar 5, 2026
36m 44s
Magnus Unemo on Zoliflodacin treatment for gonorrhea
Feb 5, 2026
16m 07s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 6/24/26 | Antimicrobial resistance National Action Plans and the role of microbial genomics with with Kate Baker and Tess Johnson | In this episode, we discuss antimicrobial resistance (AMR) priorities, as outlined in the UK National Action Plan (NAP) for AMR, and how microbial genomics can contribute to meeting them in the UK and beyond. Guests Kate Baker, a researcher at the Department of Genetics, University of Cambridge (Cambridge, UK) and Tess Johnson, a bioethicist at the Ethox Centre of the University of Oxford (Oxford, UK) explain the context in which NAPs for AMR are develped in individual countries, and specifically in the UK, following the first release of WHO's AMR Global Action Plan (GAP) in 2015 and its subsequent update adopted at the 79th World Health Assembly in 2026. They then run us through the outcomes of a stakeholder workshop of the UK Transdisciplinary Antimicrobial Resistance Genomics Network (TARGetAMR) and detail how microbial genomics can be mapped onto all the key priorities of the UK AMR NAP, and highlight key areas that need further development and who the key players in addressing these gaps should be. Finally, they expand their discussion beyond the UK, highlighting how their findings, might or might not be transferrable to other countries. In their conversation, they also mention a TARGetAMR comic, which can be found here https://www.targetamr.org.uk/our-comic/ Click here to read the full article: https://doi.org/10.1016/j.lanmic.2026.101372 | 33m 53s | ||||||
| 5/25/26 | Henriette Nielsen on vaginal microbiota transplantation | Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.” Together, they explore the study’s key findings, its implications for women’s health, and the growing importance of vaginal microbiota transplantation as a research frontier. They also reflect on what lies ahead for this emerging field. https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00222-8/fulltext | 16m 53s | ||||||
| 4/13/26 | Zakiul Hassan and Tahmina Shirin on Nipah virus disease | Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues. We also discuss Nipah virus disease more broadly, talking about recent phylogenetic findings, diagnostics, therapeutics, vaccines, and ongoing challenges. Read the systematic review here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00223-X/fulltext We also touched on some past Lancet publications, which you can explore here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00361-0/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00262-7/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00765-5/fulltext https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00707-7/fulltext https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00270-2/fulltext | 37m 01s | ||||||
| 3/5/26 | Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing | Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight... | 36m 44s | ||||||
| 2/5/26 | Magnus Unemo on Zoliflodacin treatment for gonorrhea | Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial for gonorrhea—revealing insights that could change the future of treatment and antibiotic resistance. Click here to read the full articles: https://www.thelancet.com/journals/lanmic/article/PI... | 16m 07s | ||||||
| 1/6/26 | Amber Barton on mass drug administration to eradicate yaws in Papua New Guinea | Phoebe Ashley-Norman of The Lancet Microbe speaks to Amber Barton about the neglected tropical disease, yaws. Efforts to eradicate yaws were first made in the 1950s through a WHO and UNICEF campaign that reduced yaws prevalence by 90%, but it remained endemic in some regions. Global efforts involving the mass drug administration of azithromycin continue in pursuit of the WHO 2030 yaws eradication goal. In this podcast, Amber discusses how genomic epidemiology can be used to investigate ... | 21m 34s | ||||||
| 12/22/25 | Britt Koskella on bacteriophages as a signature of microbiome health | Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Britt Koskella about bacteriophages and phageome, their role in modulating the bacteriome, their potential use as signatures of microbiome health and dysbiosis, and hence, indirectly, as markers of host health and disease status. From an ecological perspective, parasites (such as bacteriophages) are key drivers of the evolution of their hosts (bacteria), and so one might expect to find diverse and rich bacteriomes in the presence of... | 27m 53s | ||||||
| 11/3/25 | Christian Malaka and Livia Patrono on the surveillance of mpox in the Central African Republic | Rebecca Barksby of The Lancet Microbe speaks to Dr Christian Malaka and Dr Livia Patrono on mpox in the Central African Republic and how researchers are using genomic surveillance to provide insights into the epidemiology of the virus. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00101-6/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thela... | 33m 48s | ||||||
| 10/7/25 | Sam Lipworth and Nicole Stoesser on genotypic and phenotypic antimicrobial resistance in Escherichia coli | Elena Dalla Vecchia talks with Dr Sam Lipworth and Prof Nicole Stoesser about the challenges and variability in genotypic predictions of antimicrobial resistance in Escherichia coli, about which they have published two papers in The Lancet Microbe: “Exploring uncatalogued genetic variation in antimicrobial resistance gene families in Escherichia coli: an observational analysis” and “Estimating the association of antimicrobial resistance genes with minimum inhibitory concentration in Escherich... | 25m 46s | ||||||
| 4/1/25 | Anastasia Theodosiou on controlled human infection with Neisseria lactamica in pregnancy | Rebecca Barksby of The Lancet Microbe speaks to Dr Anastasia Theodosiou about performing a controlled human infection study in pregnant women investigating mother-to-infant transmission of Neisseria lactamica. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00254-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://... | 30m 06s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/25/25 | Susan Meiring, Vanessa Quan, and Nelesh Govender on bloodstream infections in neonates in South Africa | Elena Dalla Vecchia of The Lancet Microbe speaks to Susan Meiring, Vanessa Quan, and Nelesh Govender about bloodstream infections in neonates at lower-tier South African hospitals. Read the full paper, Pathogen aetiology and risk factors for death among neonates with bloodstream infections at lower-tier South African hospitals: a cross-sectional study, at https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00257-X/fulltext Continue this conversation on social! Follow us today a... | 25m 42s | ||||||
| 8/5/24 | Laurence Armand-Lefevre and Luc Samison on surveillance of antimicrobial resistant Escherichia coli in humans, chickens, and the environment in Madaga... | Rebecca Barksby of The Lancet Microbe speaks to Professor Laurence Armand-Lefevre and Professor Luc Hervé Samison about implementing the WHO Tricycle Protocol in Madagascar for the surveillance of extended-spectrum β-lactamase producing Escherichia coli in humans, chickens, and the environment. Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00228-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_eclinm Continue this conversation on social! Follow us t... | 26m 40s | ||||||
| 7/9/24 | Zoe Dyson and Philip Ashton on Salmonella enterica serotypes Typhi and Paratyphi A | Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Zoe Dyson and Dr Philip Ashton about the genomic characterisation of population diversity, antimicrobial resistance profiles, and transmission patterns of Salmonella enterica serotypes Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company... | 31m 35s | ||||||
| 5/24/24 | Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh on Streptococcus pyogenes | Elena Dalla Vecchia of The Lancet Microbe speaks to Edwin Armitage, Saffiatou Darboe, and Lamin Jaiteh about Streptococcus pyogenes carriage and transmission in households in The Gambia. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00046-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancet... | 27m 29s | ||||||
| 3/27/24 | Martin Hoenigl on climate change and fungal diseases | Rebecca Barksby of The Lancet Microbe speaks with Professor Martin Hoenigl about the impact of climate change and natural disasters on fungal diseases. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(24)00039-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com... | 36m 22s | ||||||
| 3/1/24 | Nancy Chow on sporotrichosis | Rebecca Barksby of The Lancet Microbe speaks to Dr Nancy Chow about sporotrichosis and discusses a genomic epidemiology study of this zoonotic fungal disease among people and cats in Brazil. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00364-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thela... | 22m 29s | ||||||
| 2/12/24 | Deborah Williamson and Michael Moso on detecting on-SARS-CoV-2 viruses from COVID-19 rapid antigen test devices | Elena Dalla Vecchia of The Lancet Microbe speaks to Deborah Williamson and Michael Moso about non-SARS-CoV-2 respiratory viral detection from COVID-19 rapid antigen test devices. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00375-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicalj... | 20m 05s | ||||||
| 11/23/23 | Kate Baker on harnessing genomics for antimicrobial resistance surveillance | Rebecca Barksby of The Lancet Microbe speaks to Professor Kate Baker about the challenges, potential, and recommendations for using genomics to monitor antimicrobial resistance. Read the full Series: https://www.thelancet.com/series/amr-genomics?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-... | 20m 22s | ||||||
| 8/2/23 | Erica Furhmeister on monitoring antimicrobial resistance using faecal metagenomes | Rebecca Barksby of The Lancet Microbe talks to Dr Erica Furhmeister about monitoring antimicrobial resistance using faecal metagenomes. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00137-4/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lan... | 19m 48s | ||||||
| 6/9/23 | Jie Zhou and Anika Singanayagam on their SARS-CoV-2 human challenge study | Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Jie Zhou and Dr Anika Singanayagam about their SARS-CoV-2 human challenge study. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00101-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the... | 20m 53s | ||||||
| 5/31/23 | Hanna Ehrlich on antimalarial drug resistance surveillance | Elena Dalla Vecchia of The Lancet Microbe speaks to Dr Hanna Ehrlich about antimalarial drug resistance surveillance and her recent cross-sectional study using xenomonitoring in Burkina Faso. Read the full article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thel... | 32m 20s | ||||||
| 5/31/23 | Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludiques (en français) | Elena Dalla Vecchia du The Lancet Microbe converse avec Dr Fabrice Somé sur la surveillance de la résistance aux médicaments antipaludique et son étude récent qui a utilisé la xenosurveillance en Burkina Faso. Pour lire l’article: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(23)00063-0/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanmic Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https:... | 32m 17s | ||||||
| 3/8/23 | Nichola Calvani on gender equity in science | Rebecca Barksby of The Lancet Microbe talks to Dr Nichola Calvani about gender equity in science and Herminthology, an online initiative that produces online profiles of women working in parasitology. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv | 22m 14s | ||||||
| 1/13/23 | Michael Otto on using probiotics to reduce Staphylococcus aureus | Rebecca Barksby of The Lancet Microbe talks to Dr Michael Otto and his and his collaborators’ placebo-controlled phase 2 trial that used the probiotic Bacillus subtilis to reduce Staphylococcus aureus in adults who were colonised by the bacteria in the Songkhla region of Thailand. Read the full article: Probiotic for pathogen-specific Staphylococcus aureus decolonisation in Thailand Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.c... | 20m 42s | ||||||
| 12/1/22 | David Cameron on phage therapy | Elena Dalla Vecchia of The Lancet Microbe speaks to Dr David Cameron about phage therapy and his and his colleagues’ recent systematic review and meta-analysis of the efficacy of phage therapy in preclinical models of bacterial infection. Read the full article: Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgr... | 9m 35s | ||||||
Showing 25 of 27
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.